(ANSA) – WASHINGTON, 08 JUL – Pfizer and BioNTech have announced that in the coming weeks they will ask regulatory authorities, including the FDA in the US and the EMA in the EU, for authorization for the third dose of the anti Covid vaccine. The move comes after initial “encouraging” data from a clinical trial, which showed that a third injection increases the level of antibodies 5 to 10 times against the parent strain and the Beta variant compared to the first two doses. The drug companies plan to publish more definitive data soon. (HANDLE).
REPRODUCTION RESERVED © Copyright ANSA
Get the embed code